• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆尾加压素II与高血压风险之间的关联:一项前瞻性研究的结果

Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study.

作者信息

Xie Huijian, Wang Xinya, He Yan, Huang Daoyi, Qu Xinyuan, Jiang Yanbo, An Yan, Zhang Shaoyan, Zhang Mingzhi

机构信息

Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, China.

Center for Disease Prevention and Control of Pudong New District, Shanghai 200120, China.

出版信息

Int J Hypertens. 2020 Jan 30;2020:3284769. doi: 10.1155/2020/3284769. eCollection 2020.

DOI:10.1155/2020/3284769
PMID:32099671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7013293/
Abstract

Up to date, human urotensin II (UII) is the most potent vasoconstrictor in mammalian animals. To explore whether UII played an important role in the development of hypertension, we conducted a prospective study in Changshu city, China. The baseline investigation was carried out in 2007, and the first follow-up investigation was conducted in 2013. From the participants, we randomly obtained 2000 normotensive subjects aged 40 years and older without any severe disease at baseline and examined plasma UII and endothelin-1 (ET-1) with their blood samples at baseline. Logistic models were used to analyze the association between baseline UII, baseline ET-1, and newly occurring hypertension. In 1,819 subjects with complete data, 723 subjects developed into hypertensive in about five years. After adjusting some potential confounders, the odds ratio (95% confidence interval) for risk of hypertension comparing the highest with the lowest quartile of baseline UII was 0.888 (0.689-1.144). The role of UII in the development of hypertension was not found in the current study; therefore, further research studies should be conducted to explore the relationship between UII and hypertension.

摘要

迄今为止,人尾加压素II(UII)是哺乳动物中最有效的血管收缩剂。为了探讨UII在高血压发生发展中是否起重要作用,我们在中国常熟市进行了一项前瞻性研究。基线调查于2007年进行,首次随访调查于2013年进行。我们从参与者中随机选取了2000名40岁及以上的血压正常受试者,这些受试者在基线时无任何严重疾病,并在基线时采集他们的血样检测血浆UII和内皮素-1(ET-1)。采用逻辑模型分析基线UII、基线ET-1与新发高血压之间的关联。在1819名有完整数据的受试者中,约五年内有723名受试者发展为高血压患者。在调整了一些潜在混杂因素后,将基线UII最高四分位数与最低四分位数相比,高血压风险的比值比(95%置信区间)为0.888(0.689 - 1.144)。在本研究中未发现UII在高血压发生发展中的作用;因此,应开展进一步的研究来探讨UII与高血压之间的关系。

相似文献

1
Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study.血浆尾加压素II与高血压风险之间的关联:一项前瞻性研究的结果
Int J Hypertens. 2020 Jan 30;2020:3284769. doi: 10.1155/2020/3284769. eCollection 2020.
2
Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.高血压大鼠心血管器官中尾加压素II、尾加压素II相关肽及尾加压素II受体mRNA表达增加:与内皮素-1的比较
Peptides. 2009 Jun;30(6):1124-9. doi: 10.1016/j.peptides.2009.02.009. Epub 2009 Feb 21.
3
Renal impairment, hypertension and plasma urotensin II.肾功能损害、高血压与血浆尾加压素Ⅱ。
Nephrol Dial Transplant. 2011 Feb;26(2):609-14. doi: 10.1093/ndt/gfq416. Epub 2010 Jul 9.
4
Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout.
Comp Biochem Physiol C Toxicol Pharmacol. 2016 May-Jun;183-184:53-60. doi: 10.1016/j.cbpc.2016.01.006. Epub 2016 Feb 21.
5
Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.尾加压素II对无心力衰竭或原发性高血压的糖尿病患者皮肤微血管张力的影响。
Clin Exp Pharmacol Physiol. 2008 Oct;35(10):1147-50. doi: 10.1111/j.1440-1681.2008.04960.x. Epub 2008 May 23.
6
H2 S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II.硫化氢抑制肝星状细胞的活化并下调尾加压素 II 的表达。
Hepatol Res. 2013 Jun;43(6):670-8. doi: 10.1111/hepr.12002. Epub 2012 Nov 7.
7
Association between essential hypertension and three vasoactive peptides, urotensin II, endothelin and adrenomedullin.原发性高血压与三种血管活性肽(尾加压素 II、内皮素和肾上腺髓质素)的关系。
Clin Exp Hypertens. 2015;37(7):604-8. doi: 10.3109/10641963.2015.1047940. Epub 2015 Jul 24.
8
Does cigarette smoking increase plasma urotensin II concentrations?吸烟会增加血浆尾加压素II浓度吗?
Eur J Clin Pharmacol. 2007 Mar;63(3):253-7. doi: 10.1007/s00228-006-0252-6. Epub 2007 Jan 25.
9
The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.冠状动脉慢血流现象与尾加压素 -II 的关系:一项前瞻性对照研究。
Anatol J Cardiol. 2015 Jun;15(6):475-9. doi: 10.5152/akd.2014.5481. Epub 2014 Apr 28.
10
Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout.鱼的尾加压素II及尾加压素II相关肽对心脏压力反射敏感性的中枢及外周效应
Front Neurosci. 2017 Feb 10;11:51. doi: 10.3389/fnins.2017.00051. eCollection 2017.

引用本文的文献

1
The Inhibitory Role of Hydrogen Sulfide in UII-Induced Cardiovascular Effects and the Underlying Signaling Pathways.硫化氢在乌拉立肽诱导的心血管效应及潜在信号通路中的抑制作用
Antioxidants (Basel). 2022 Nov 15;11(11):2253. doi: 10.3390/antiox11112253.

本文引用的文献

1
Endothelin-1 and angiotensin-II modulate urotensin-II vasoconstriction in rat aorta exposed to mercury.内皮素-1和血管紧张素-II调节暴露于汞的大鼠主动脉中的尾加压素-II血管收缩作用。
Bratisl Lek Listy. 2018;119(7):444-449. doi: 10.4149/BLL_2018_081.
2
YKL-40 Level and Hypertension Incidence: A Population-Based Nested Case-Control Study in China.YKL-40水平与高血压发病率:一项基于中国人群的巢式病例对照研究
J Am Heart Assoc. 2016 Nov 4;5(11):e004534. doi: 10.1161/JAHA.116.004534.
3
Association between essential hypertension and three vasoactive peptides, urotensin II, endothelin and adrenomedullin.原发性高血压与三种血管活性肽(尾加压素 II、内皮素和肾上腺髓质素)的关系。
Clin Exp Hypertens. 2015;37(7):604-8. doi: 10.3109/10641963.2015.1047940. Epub 2015 Jul 24.
4
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
5
Urotensin-II system in genetic control of blood pressure and renal function.尿皮质素-II 系统在血压和肾功能的遗传控制中的作用。
PLoS One. 2013 Dec 31;8(12):e83137. doi: 10.1371/journal.pone.0083137. eCollection 2013.
6
Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.人尾加压素II与原发性高血压的关联——一项1:1匹配病例对照研究。
PLoS One. 2013 Dec 10;8(12):e81764. doi: 10.1371/journal.pone.0081764. eCollection 2013.
7
Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease.冠心病患者血浆中内皮素-1和尾加压素-II水平升高。
Heart Vessels. 2010 Mar;25(2):138-43. doi: 10.1007/s00380-009-1178-6. Epub 2010 Mar 26.
8
Urotensin II-induced increase in myocardial distensibility is modulated by angiotensin II and endothelin-1.尾加压素 II 诱导的心肌顺应性增加受血管紧张素 II 和内皮素-1 的调节。
Physiol Res. 2009;58(5):653-660. doi: 10.33549/physiolres.931524. Epub 2008 Nov 4.
9
Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension.在原发性高血压中,人尿钠素II水平升高与颈动脉粥样硬化相关。
Am J Hypertens. 2007 Feb;20(2):211-7. doi: 10.1016/j.amjhyper.2006.08.001.
10
Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension.
Int J Cardiol. 2006 Jun 16;110(2):175-8. doi: 10.1016/j.ijcard.2005.07.008. Epub 2005 Sep 28.